Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q2 2023 Earnings Call Transcript August 8, 2023
Amphastar Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.65, expectations were $0.57.
Operator: Greetings and welcome to the Amphastar Pharmaceuticals Second Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that certain statements made during...
